Cite
HARVARD Citation
Tscholl, V. et al. (2017). Prospective randomized study evaluating the effects of PerClot® (Polysaccharide Hemostatic System) application in patients with high bleeding risk undergoing cardiac rhythm device implantation. International journal of cardiology. pp. 84-91. [Online].